Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02012491 · ClinicalTrials.gov registry record · Phase 3
Comparative Effectiveness of Pregnancy Failure Management Regimens
A Phase 3 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 3
- Development phase
- 300
- Enrollment target
NCT02012491: Completed Phase 3 study, sponsored by University of Pennsylvania.
NCT02012491 is a Phase 3 study that has completed, run by University of Pennsylvania. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02012491, a Phase 3 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 300 participants
- Enrollment target
Study Summary
The purpose of the study is to compare the effectiveness of combination treatment (mifepristone premedication plus single-dose misoprostol) to single-dose misoprostol (standard of care) for the management of early pregnancy failure.
Interventions
- DRUG Mifepristone
- DRUG Misoprostol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2014-01 |
| Est. Completion | 2019-06-15 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02012491
The ClinicalTrials.gov registry entry for NCT02012491 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mifepristone is the first listed.
NCT02012491 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02012491 about?
NCT02012491 is a clinical study titled "Comparative Effectiveness of Pregnancy Failure Management Regimens". The purpose of the study is to compare the effectiveness of combination treatment (mifepristone premedication plus single-dose misoprostol) to single-dose misoprostol (standard of care) for the management of early pregnancy failure.
What is the current status of trial NCT02012491?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 300 participants. The study started on 2014-01. Estimated completion is 2019-06-15.
What interventions are being tested in trial NCT02012491?
The interventions under investigation include: Mifepristone (DRUG), Misoprostol (DRUG).
Who is sponsoring clinical trial NCT02012491?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.